Does GENTAMICIN Cause Product use in unapproved indication? 313 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 313 reports of Product use in unapproved indication have been filed in association with GENTAMICIN (Gentamicin). This represents 4.8% of all adverse event reports for GENTAMICIN.
313
Reports of Product use in unapproved indication with GENTAMICIN
4.8%
of all GENTAMICIN reports
27
Deaths
60
Hospitalizations
How Dangerous Is Product use in unapproved indication From GENTAMICIN?
Of the 313 reports, 27 (8.6%) resulted in death, 60 (19.2%) required hospitalization, and 28 (8.9%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GENTAMICIN. However, 313 reports have been filed with the FAERS database.
What Other Side Effects Does GENTAMICIN Cause?
Acute kidney injury (1,026)
Drug ineffective (824)
Off label use (363)
Maternal exposure during pregnancy (360)
Foetal exposure during pregnancy (324)
Premature baby (315)
Pyrexia (302)
Premature delivery (283)
Condition aggravated (252)
Drug hypersensitivity (214)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which GENTAMICIN Alternatives Have Lower Product use in unapproved indication Risk?
GENTAMICIN vs GEODON
GENTAMICIN vs GIANVI
GENTAMICIN vs GILENYA
GENTAMICIN vs GILOTRIF
GENTAMICIN vs GILTERITINIB